BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12419883)

  • 1. Effects of KMD-3213, a uroselective alpha 1A-adrenoceptor antagonist, on the tilt-induced blood pressure response in normotensive rats.
    Akiyama K; Hora M; Yamagishi R; Kitazawa M
    Jpn J Pharmacol; 2002 Oct; 90(2):131-7. PubMed ID: 12419883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.
    Akiyama K; Hora M; Tatemichi S; Masuda N; Nakamura S; Yamagishi R; Kitazawa M
    J Pharmacol Exp Ther; 1999 Oct; 291(1):81-91. PubMed ID: 10490890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of silodosin (KMD-3213) on phenylephrine-induced increase in intraurethral pressure and blood pressure in rats--study of the selectivity for lower urinary tract].
    Tatemichi S; Kobayashi K; Maruyama I; Kobayashi M; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():217-23. PubMed ID: 16518086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of KMD-3213, an alpha1A-adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs.
    Akiyama K; Noto H; Nishizawa O; Sugaya K; Yamagishi R; Kitazawa M; Tsuchida S
    Int J Urol; 2001 Apr; 8(4):177-83. PubMed ID: 11260350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KMD-3213, a novel alpha1A-adrenoceptor antagonist, potently inhibits the functional alpha1-adrenoceptor in human prostate.
    Moriyama N; Akiyama K; Murata S; Taniguchi J; Ishida N; Yamazaki S; Kawabe K
    Eur J Pharmacol; 1997 Jul; 331(1):39-42. PubMed ID: 9274928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta.
    Yamagishi R; Akiyama K; Nakamura S; Hora M; Masuda N; Matsuzawa A; Murata S; Ujiie A; Kurashina Y; Iizuka K; Kitazawa M
    Eur J Pharmacol; 1996 Nov; 315(1):73-9. PubMed ID: 8960867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
    Yamada S; Ohkura T; Kimura R; Kawabe K
    Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha1-adrenoceptor antagonists on agonist and tilt-induced changes in blood pressure: relationships to uroselectivity.
    Hieble JP; Kolpak DC; McCafferty GP; Ruffolo RR; Testa R; Leonardi A
    Eur J Pharmacol; 1999 May; 373(1):51-62. PubMed ID: 10408251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective alpha1A-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia.
    Tatemichi S; Akiyama K; Kobayashi M; Yamazaki Y; Yokoyama O; Uruno T
    J Urol; 2006 Sep; 176(3):1236-41. PubMed ID: 16890732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.
    Chen Z; Ishizuka O; Imamura T; Aizawa N; Igawa Y; Nishizawa O; Andersson KE
    Neurourol Urodyn; 2009; 28(3):251-6. PubMed ID: 18837433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of JTH-601, a novel alpha1-adrenoceptor antagonist, on the function of lower urinary tract and blood pressure.
    Suzuki Y; Kanada A; Okaya Y; Aisaka K; Muramatsu I
    Eur J Pharmacol; 1999 Jun; 374(3):495-502. PubMed ID: 10422795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
    Tatemichi S; Tomiyama Y; Maruyama I; Kobayashi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
    Neurourol Urodyn; 2006; 25(7):792-9; discussion 800-1. PubMed ID: 16894620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between prostatic alpha(1)-adrenoceptor binding and reduction in intraurethral pressure following continuous infusion of KMD-3213 in rats.
    Akiyama K; Tatemichi S; Katayama S; Nakajima M; Oki T; Okura T; Yamada S; Kimura R
    Pharmacology; 2002; 64(3):140-7. PubMed ID: 11834890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
    Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duration of action of silodosin (KMD-3213) against phenylephrine-induced increase in intraurethral pressure in rats].
    Kobayashi M; Tatemichi S; Kobayashi K; Imamura T; Maruyama I; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():231-6. PubMed ID: 16518088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
    Murata S; Taniguchi T; Muramatsu I
    Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.
    Brune ME; Katwala SP; Milicic I; Witte DG; Kerwin JF; Meyer MD; Hancock AA; Williams M
    J Pharmacol Exp Ther; 2002 Feb; 300(2):487-94. PubMed ID: 11805208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)].
    Tatemichi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():209-16. PubMed ID: 16518085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
    Shibata K; Foglar R; Horie K; Obika K; Sakamoto A; Ogawa S; Tsujimoto G
    Mol Pharmacol; 1995 Aug; 48(2):250-8. PubMed ID: 7651358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.